News
![Verona Pharma's David Zaccardelli](/sites/default/files/styles/x_large/public/2024-01/David-Zaccardelli-Verona_pharma.jpg?itok=fketEt3_)
Verona cuts $400m loan deal as it preps COPD drug for market
Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch o